Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
Abroad (travel likely)RecruitingEARLY_PHASE1
Conditions
Pancreatic Cancer · Pancreatic Ductal Adenocarcinoma · PDAC · PDAC - Pancreatic Ductal Adenocarcinoma · Pancreatic Neoplasm
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Matthew Yurgelun, MD) · matthew_yurgelun@dfci.harvard.edu · 617-582-8673Contact: Principal Investigator (Matthew Yurgelun, MD)Dana Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Matthew Yurgelun, MD) · matthew_yurgelun@dfci.harvard.edu · 617-582-8673Contact: Principal Investigator (Matthew B Yurgelun, MD)
Study leads
Matthew Yurgelun, MD
Principal Investigator
Dana-Farber Cancer Institute